4
Changes in Ownership
BECTON DICKINSON & CO Filed Acc 0001628280-25-054855
EVP, CRO & Pres. Life Sciences sold 75 shares at $193.36 ($14,502)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Feld Michael · EVP, CRO & Pres. Life Sciences
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Sale : show line 1 in the form 10b5-1 | −75 | $193.36 | $14,502 | 16,580 | D |
| Open-market sales · 75 sh · avg $193.36 · $14,502 | ||||||
Loading xslF345X05/wk-form4_1764717914.xml…